Biobanking - Evaluating the Benefits of Public-Private Partnerships

Biobanking - Evaluating the Benefits of Public-Private Partnerships
Cutting edge research as well as further innovations in the life science industry will strongly depend on transnational access to high quality human biological data derived from samples, and to the associated medical information, all of which must be accessible to both academia and industry in an efficient and secure manner. In this interview Heli Salimen-Mankonen, Research Director, Auria Biobank, speaks about forming and sustaining public-private partnerships and the evaluating the benefits of this collaboration.

Please note: That all fields marked with an asterisk (*) are required.